SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-21-072311
Filing Date
2021-03-08
Accepted
2021-03-08 08:10:32
Documents
15
Period of Report
2021-03-05
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d147986d8k.htm   iXBRL 8-K 27566
2 EX-4.1 d147986dex41.htm EX-4.1 25162
3 EX-4.2 d147986dex42.htm EX-4.2 53513
4 EX-99.1 d147986dex991.htm EX-99.1 28325
  Complete submission text file 0001193125-21-072311.txt   285733

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA qtnt-20210305.xsd EX-101.SCH 3074
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE qtnt-20210305_lab.xml EX-101.LAB 18838
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE qtnt-20210305_pre.xml EX-101.PRE 11841
8 EXTRACTED XBRL INSTANCE DOCUMENT d147986d8k_htm.xml XML 3568
Mailing Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA
Business Address 28 ESPLANADE SAINT HELIER Y9 JE2 3QA 41274832286
Quotient Ltd (Filer) CIK: 0001596946 (see all company filings)

IRS No.: 264719797 | State of Incorp.: Y9 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-36415 | Film No.: 21720676
SIC: 2835 In Vitro & In Vivo Diagnostic Substances